Find clinical trials for Heart Disease in Valencia, VC
CTV is a public benefit provided by Veeva Systems to help you find the most relevant clinical trials for you and your loved ones
Related conditions:
Heart Disease trials near Valencia, VC, ESP:
tomography (OCT) findings indicative of vulnerable plaque, in patients with ST-elevation myocardial infarction (STEMI) and multivessel disease...
Valencia, Spain and 45 other locations
of this study is to evaluate the safety and effectiveness of tovinontrine compared to placebo to lower NT-proBNP in patients with chronic heart...
Phase 2
Valencia, Spain and 139 other locations
The purpose of this study is to establish the safety and effectiveness of pulsed field ablation as a first-line ablation treatment for subjects with...
Valencia, Spain and 63 other locations
This study will look at the effects of CagriSema on cardiovascular events (for example heart attack and stroke) in people living with cardio...
Phase 3
Valencia, Spain and 569 other locations
The main purpose of this study is to determine if retatrutide can significantly lower the incidence of serious heart-related complications o...
Phase 3
Valencia, Spain and 826 other locations
The primary objective of this study is to assess the efficacy of a single dose of ravulizumab IV compared with placebo in reducing the risk of the cl...
Phase 3
Valencia, Spain and 171 other locations
of Epstein-Barr virus-associated post-transplant lymphoproliferative disease (EBV+ PTLD) in the setting of (1) solid organ transplant (SOT) ...
Phase 3
Valencia, Valencia, Spain and 70 other locations
leads to dyssynchronous electrical and mechanical activation of the ventricles, and may cause pacing-induced cardiomyopathy and heart...
Valencia, Spain and 12 other locations
stable dose for management of high blood pressure, diabetes, kidney disease, etc. for at least 4 weeks before the start of the studyPeople c...
Phase 2
Valencia, Spain and 156 other locations
The primary objective of this study is to compare the effect of treatment with olpasiran, to placebo, on the risk for coronary heart disease...
Phase 3
Valencia, Valencia, Spain and 742 other locations
Clinical trials
Research sites
Resources
Legal